SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-14-060653
Filing Date
2014-10-10
Accepted
2014-10-10 16:15:33
Documents
11
Period of Report
2014-10-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K v391116_8k.htm 8-K 26370
2 EXHIBIT 3.1 v391116_ex3-1.htm EX-3.1 13794
3 EXHIBIT 10.1 v391116_ex10-1.htm EX-10.1 30170
4 EXHIBIT 99.1 v391116_ex99-1.htm EX-99.1 13607
5 EXHIBIT 99.2 v391116_ex99-2.htm EX-99.2 14483
6 GRAPHIC image_001.jpg GRAPHIC 4013
7 GRAPHIC image_002.jpg GRAPHIC 5662
8 GRAPHIC tlogo2.jpg GRAPHIC 8341
9 GRAPHIC tlogo1.jpg GRAPHIC 10117
10 GRAPHIC tlogo3.jpg GRAPHIC 2529
11 GRAPHIC tsig.jpg GRAPHIC 11289
  Complete submission text file 0001144204-14-060653.txt   158753
Mailing Address C/O JANSSEN LABS @ QB3 953 INDIANA STREET SAN FRANCISCO CA 94107
Business Address C/O JANSSEN LABS @ QB3 953 INDIANA STREET SAN FRANCISCO CA 94107 (408) 737-2734
Amarantus Bioscience Holdings, Inc. (Filer) CIK: 0001424812 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55016 | Film No.: 141152580
SIC: 2834 Pharmaceutical Preparations